Implementing the EU Falsified Medicines Directive

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 2019 English Publisher:WileyJournal:Prescriber, volume 30, pages 30-33 (issn: 0959-6682, eissn: 1931-2253,

Copyright policy )

Authors: Joy Ogden;

doi: 10.1002/psb.1748

Implementing the EU Falsified Medicines Directive

- Summary
- Metrics

Abstract

The European Union's Falsified Medicines Directive, which came into force on 9 February, has laid down rigorous rules for pharmaceutical companies and pharmacists to follow in a bid to eradicate the pernicious impact of fake drugs infiltrating the legal supply chain. Joy Ogden reports on the progress so far.

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average